Phase 3 Trial of ¹⁷⁷Lu-Dotatate for Midgut Neuroendocrine Tumors

JOURNAL ARTICLE published 12 January 2017 in New England Journal of Medicine

Authors: Jonathan Strosberg | Ghassan El-Haddad | Edward Wolin | Andrew Hendifar | James Yao | Beth Chasen | Erik Mittra | Pamela L. Kunz | Matthew H. Kulke | Heather Jacene | David Bushnell | Thomas M. O’Dorisio | Richard P. Baum | Harshad R. Kulkarni | Martyn Caplin | Rachida Lebtahi | Timothy Hobday | Ebrahim Delpassand | Eric Van Cutsem | Al Benson | Rajaventhan Srirajaskanthan | Marianne Pavel | Jaime Mora | Jordan Berlin | Enrique Grande | Nicholas Reed | Ettore Seregni | Kjell Öberg | Maribel Lopera Sierra | Paola Santoro | Thomas Thevenet | Jack L. Erion | Philippe Ruszniewski | Dik Kwekkeboom | Eric Krenning